Chiara Corti

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 15

Top Venues

Cancers

NPJ breast cancer

JCO oncology practice

Current oncology (Toronto, Ont.)

Università degli Studi di Milano (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Università degli Studi di Milano Nov 01 2019

Italy

PHD :: Medical Oncology

Università degli Studi di Milano Oct 01 2012 - Jul 24 2018

Italy

PHD

Publications

Gianluca Spitaleri, Pamela Trillo Aliaga, Ilaria Attili, Ester Del Signore, Carla Corvaja, Chiara Corti, Jacopo Uliano, Antonio Passaro, Filippo de Marinis
MET in Non-Small-Cell Lung Cancer (NSCLC): Cross 'a Long and Winding Road' Looking for a Target. Cancers 15 (19) (2023)
Chiara Corti, Federica Giugliano, Eleonora Nicolò, Paolo Tarantino, Carmen Criscitiello, Curigliano Giuseppe
HER2-Low Breast Cancer: a New Subtype? Current treatment options in oncology (2023)
Federica Giugliano, Ambra Carnevale Schianca, Chiara Corti, Mariia Ivanova, Nadia Bianco, Silvia Dellapasqua, Carmen Criscitiello, Nicola Fusco, Curigliano Giuseppe, Elisabetta Munzone
Unlocking the Resistance to Anti-HER2 Treatments in Breast Cancer: The Issue of HER2 Spatial Distribution. Cancers 15 (5) (2023)
Federica Giugliano, Ambra Carnevale Schianca, Chiara Corti, Mariia Ivanova, Nadia Bianco, Silvia Dellapasqua, Carmen Criscitiello, Nicola Fusco, Curigliano Giuseppe, Elisabetta Munzone
Unlocking the Resistance to Anti-HER2 Treatments in Breast Cancer: The Issue of HER2 Spatial Distribution. Cancers 15 (5) (2023)
Paola Zagami, Dario Trapani, Eleonora Nicolò, Chiara Corti, Carmine Valenza, Carmen Criscitiello, Curigliano Giuseppe, Lisa Anne Carey
Cardiotoxicity of Agents Used in Patients With Breast Cancer. JCO oncology practice (2023)
Gianluca Spitaleri, Pamela Trillo Aliaga, Ilaria Attili, Ester Del Signore, Carla Corvaja, Chiara Corti, Edoardo Crimini, Antonio Passaro, Filippo de Marinis
Sustained Improvement in the Management of Patients with Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocation: Where Are We Running? Current oncology (Toronto, Ont.) 30 (5) (2023)
Emma Zattarin, Daniele Presti, Luigi Mariani, Caterina Sposetti, Rita Leporati, Alice Menichetti, Chiara Corti, Chiara Benvenuti, Giovanni Fucà, Riccardo Lobefaro, Francesca Ligorio, Leonardo Provenzano, Andrea Vingiani, Marta Del Vecchio, Gaia Griguolo, Marianna Sirico, Ottavia Bernocchi, Antonio Marra, Paola Zagami, Elisa Agostinetto, Flavia Jacobs, Pierluigi di Mauro, Andrea Esposito, Carlo Alberto Giorgi, Luca Lalli, Laura Boldrini, Pier Paolo Berton Giacchetti, Ambra Carnevale Schianca, Valentina Guarneri, Rebecca Pedersini, Agnese Losurdo, Alberto Zambelli, Daniele Generali, Carmen Criscitiello, Curigliano Giuseppe, Giancarlo Pruneri, Filippo de Braud, Maria Vittoria Dieci, Claudio Vernieri
Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors. NPJ breast cancer 9 (1) (2023)
Chiara Corti, Konstantinos Venetis, Elham Sajjadi, Lorenzo Zattoni, Curigliano Giuseppe, Nicola Fusco
CAR-T cell therapy for triple-negative breast cancer and other solid tumors: preclinical and clinical progress. Expert opinion on investigational drugs 31 (6) (2022)
Carmen Criscitiello, Chiara Corti
Breast Cancer Genetics: Diagnostics and Treatment. Genes 13 (9) (2022)
Paolo Tarantino, Chiara Corti, Peter Schmid, Javier Cortes, Elizabeth A Mittendorf, Hope Rugo, Sara M Tolaney, Giampaolo Bianchini, Fabrice Andre, Curigliano Giuseppe
Immunotherapy for early triple negative breast cancer: research agenda for the next decade. NPJ breast cancer 8 (1) (2022)
Chiara Corti, Eleonora Nicolò, Curigliano Giuseppe
Novel immune targets for the treatment of triple-negative breast cancer. Expert opinion on therapeutic targets (2021)
Chiara Corti, Federica Giugliano, Eleonora Nicolò, Liliana Ascione, Curigliano Giuseppe
Antibody-Drug Conjugates for the Treatment of Breast Cancer. Cancers 13 (12) (2021)
Pamela Trillo Aliaga, Dario Trapani, José Luis Sandoval, Edoardo Crimini, Gabriele Antonarelli, Grazia Vivanet, Stefania Morganti, Chiara Corti, Paolo Tarantino, Alex Friedlaender, Carmen Belli, Ida Minchella, Marzia Locatelli, Angela Esposito, Carmen Criscitiello, Curigliano Giuseppe
Safety of COVID-19 mRNA Vaccines in Patients with Cancer Enrolled in Early-Phase Clinical Trials. Cancers 13 (22) (2021)
Gabriele Antonarelli, Federica Giugliano, Chiara Corti, Matteo Repetto, Paolo Tarantino, Curigliano Giuseppe
Research and Clinical Landscape of Bispecific Antibodies for the Treatment of Solid Malignancies. Pharmaceuticals (Basel, Switzerland) 14 (9) (2021)
Gianluca Lopez, Marianna Noale, Chiara Corti, Gabriella Gaudioso, Elham Sajjadi, Konstantinos Venetis, Donatella Gambini, Letterio Runza, Jole Costanza, Chiara Pesenti, Francesco Grossi, Stefania Maggi, Stefano Ferrero, Silvano Bosari, Nicola Fusco
PTEN Expression as a Complementary Biomarker for Mismatch Repair Testing in Breast Cancer. International journal of molecular sciences 21 (4) (2020)

Chiara Corti.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Chiara Corti